Applied Clinical Trials October Recap
Our October issue focused on the current state of outsourcing with additional coverage around site networks and risk-based quality management.
This October, Applied Clinical Trials focused on the topic of new-age outsourcing. Led by the rise of integrated research organizations (IROs), providers are finding new and innovative ways to design their trials. In the case of IROs, this new approach enhances diversity and access by bringing clinical trials directly to patient communities, as opposed to more traditional research sites.
On the business side of outsourcing, partnering with a functional service provider (FSP) is becoming critical. These providers are now supporting sponsors through oversight and leveraging business operations data, giving those who partner with them a clear edge in trial execution.
In addition to the current outsourcing landscape, ACT’s October issue also provided key insights on site networks and risk-based quality management (RBQM).
With November on the horizon, the following slideshow provides a look back at the previously mentioned topics we covered in October.
Image Credit: © Lucas - stock.adobe.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
